Cargando…
Clinical trial to evaluate the efficacy of botulinum toxin type A injection for reducing scars in patients with forehead laceration: A double-blinded, randomized controlled study
BACKGROUND: Botulinum toxin type A (BoNTA) is known to prevent fibroblast proliferation and expression of transforming growth factor beta 1 (TGF-β1). It also induces temporary muscle paralysis and decreases tension vectors. Fibroblasts induce scar contracture and hypertrophy by producing collagen fi...
Autores principales: | Kim, Seong Hwan, Lee, Seong Joo, Lee, Jun Won, Jeong, Hii Sun, Suh, In Suck |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6716761/ https://www.ncbi.nlm.nih.gov/pubmed/31441893 http://dx.doi.org/10.1097/MD.0000000000016952 |
Ejemplares similares
-
Clinical Trial to Evaluate the Efficacy of Botulinum Toxin Type A Injection for Reducing Scars in Patients With Forehead Laceration
por: Kim, Seong Hwan, et al.
Publicado: (2019) -
Nonallergic Eyelid Edema After Botulinum Toxin Type A Injection: Case Report and Review of Literature
por: Chang, Yin-Shuo, et al.
Publicado: (2015) -
A case of Ehlers–Danlos syndrome presenting with widened atrophic scars of forehead, elbow, knee, and pretibial area: A case report
por: Xu, Xiangwen, et al.
Publicado: (2019) -
Topical cryoanesthesia for the relief of pain caused by steroid injections used to treat hypertrophic scars and keloids
por: Wang, Xiuxia, et al.
Publicado: (2017) -
Low-level light therapy using a helmet-type device for the treatment of androgenetic alopecia: A 16-week, multicenter, randomized, double-blind, sham device-controlled trial
por: Yoon, Jung Soo, et al.
Publicado: (2020)